Vyloo
Novartis India Ltd

Rafinlar 75mg Capsule

Contains:Dabrafenib (75mg) ↗
℞
Prescription Required
Store below 30°C
MRP₹43,734.006% OFF
₹41,109.96

Inclusive of all taxes

Packaging:28 capsules
Rafinlar 75mg Capsule

Free Express Secure Delivery

Protective climate-sealed dispatch across India within 4 to 24 hours.

Composition:Dabrafenib (75mg)
Manufacturer:Novartis India Ltd
Licensed Network
Store below 30°C
Rx Verification
Express Dispatch

Financial Assistance Available

Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Rafinlar 75mg Capsule.

WhatsApp Check PAP Eligibility

About this medicine

Rafinlar 75mg Capsule (Dabrafenib (75mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.

Rafinlar 75mg Capsule should be taken at least 1 hour before or 2 hours after a meal in the dose as advised by the doctor. The duration of treatment varies on the basis of your response to the treatment. Your doctor may advice regular eye examinations while taking this medicine. You must inform the doctor if you experience eye irritation, blurred vision, eye pain, or other vision changes during your treatment. The most common side effects of this medicine include diarrhea, fever, nausea, and headache. If they do not go away or get worse, tell your doctor. There may be ways of preventing or reducing these effects. It is very strong medicine and some people may develop serious side effects while taking it. It may lower your ability to fight infections and lead to problems with your blood, liver, or kidneys. Inform your doctor if you notice unusual bleeding or bruising, lack of energy, loss of appetite, and yellowing of eyes. Your doctor will advise you regular blood tests to check for these. Before taking This medicine, tell your doctor if you have liver or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine, so let your doctor know about all the medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during the treatment with this drug is important to avoid pregnancy. There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Quick Facts

Chemical ClassSulfanilides
Habit FormingNo
Therapeutic ClassANTI NEOPLASTICS
Action ClassBRAF inhibitor

Composition / Active Salt

Dabrafenib (75mg)

Dosage Form

Capsule

Prescription Status

Doctor's Rx Required

Uses of Rafinlar 75mg Capsule

Treatment of Malignant melanoma

Side Effects of Rafinlar 75mg Capsule

Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.

Fever
Headache
Hyperkeratosis
Palmar-plantar erythrodysesthesia syndrome
Hair loss
Joint pain
Papilloma

Clinical Safety Advice for Rafinlar 75mg Capsule

Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Rafinlar 75mg Capsule.

Alcohol
CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Rafinlar 75mg Capsule. Please consult your doctor.

Pregnancy
CONSULT YOUR DOCTOR

The safety of Rafinlar 75mg Capsule during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.

Breast Feeding
CONSULT YOUR DOCTOR

Rafinlar 75mg Capsule may be unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. It should be used only if the expected benefit outweighs the potential risk. Please consult your doctor.

Driving
UNSAFE

Rafinlar 75mg Capsule may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney
CAUTION

Rafinlar 75mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.

Liver
CAUTION

Rafinlar 75mg Capsule should be used with caution in patients with liver disease. Dose adjustment may be needed.

Storage & Delivery Protocol

Preservation and climate-safe dispatch guidelines for Rafinlar 75mg Capsule across India.

Store below 30°C

Storage Conditions

Store in the original container at room temperature below 30°C (86°F). Protect from moisture and direct sunlight. Keep out of reach of children and pets. This medication does not require 2°C–8°C cold-chain refrigeration.

Climate-Sealed Transit

Dispatched in protective, tamper-evident and moisture-sealed packaging.

Rx Verification

Prescription and genuine batch validated prior to dispatch.

Frequently Asked Questions

Rafinlar 75mg Capsule is used to treat skin cancer (melanoma) caused by a specific gene mutation (BRAF V600E or V600K). This medicine by blocking the activity of BRAF, a mutated gene that regulates cell growth.

Some rare but serious side effects of Rafinlar 75mg Capsule include new cancers (like skin cancer), heart problems (shortness of breath, swelling, fast heartbeat), bleeding issues, eye inflammation (pain, vision changes), severe skin reactions, fever with chills or low blood pressure, very high blood sugar (in diabetics) and liver or blood problems.

Rafinlar 75mg Capsule can slow cancer growth, shrink tumors, and improve survival in patients with cancer. It is often used in combination with other drugs like trametinib for better results.

Some patients see tumor shrinkage within a few weeks to months, but response times vary from individual to individual. Your doctor will monitor your progress through scans and blood tests.

Rafinlar 75mg Capsule may reduce fertility in both men and women. If you plan to have children, discuss fertility preservation options with your doctor before starting treatment.

Do not stop Rafinlar 75mg Capsule without consulting your doctor. Stopping suddenly may allow the cancer to grow faster. If side effects are severe, your doctor may adjust your dose or switch treatments.

During Rafinlar 75mg Capsule treatment, doctors may regularly monitor heart function. Eye exams may be done, especially if there are vision issues. Blood sugar levels may be checked, particularly in individuals with diabetes. Liver and kidney function will also be monitored. Skin checks may be performed to look for new cancers. These tests help detect side effects early and ensure safe treatment.

No, Rafinlar 75mg Capsule is only for patients with a BRAF V600 mutation, confirmed by a lab test. It is not recommended for people whose tumors don't have this mutation.

Rafinlar (Dabrafenib) is a targeted therapy used to treat advanced cancers like melanoma, non-small cell lung cancer, and thyroid cancer that test positive for specific BRAF gene mutations.

They should be swallowed whole with a glass of water on an empty stomach (1 hour before or 2 hours after food), taken twice daily roughly 12 hours apart as directed by your oncologist.

Yes. Rafinlar is only effective for tumors that harbor specific BRAF V600 mutations, so your doctor will verify your mutation status through diagnostic testing before starting treatment.

Have questions about your cancer prescription?

Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.

WhatsApp Chat on WhatsApp Call 9220172920